SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomas

BACKGROUND: Gliomas are one of the most common primary tumors of the central nervous system, and have an unfavorable prognosis. SLC39A1 is a zinc ion transport protein which inhibits the progression of prostate cancer. By studying the role and mechanism of SLC39A1 in the progression of gliomas, perh...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Peng, Zhang, Jingjing, He, Shuai, Xiao, Boan, Peng, Xiaobin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694905/
https://www.ncbi.nlm.nih.gov/pubmed/33292262
http://dx.doi.org/10.1186/s12935-020-01675-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694905/
https://www.ncbi.nlm.nih.gov/pubmed/33292262
http://dx.doi.org/10.1186/s12935-020-01675-0

Ejemplares similares